| human | Q5 |
| P496 | ORCID iD | 0000-0003-1373-281X |
| P1053 | ResearcherID | E-9015-2017 |
| P1153 | Scopus author ID | 6505552891 |
| P10258 | UNICA IRIS author ID | 32157 |
| P69 | educated at | Department of Statistical Sciences, Sapienza University of Rome | Q60650497 |
| P108 | employer | Policlinico Umberto I | Q500377 |
| P735 | given name | Daniela | Q1096053 |
| Daniela | Q1096053 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | female | Q6581072 |
| Q39458801 | Adjuvant radiation therapy in stage I seminoma: 20 years of oncologic results |
| Q35155500 | Advanced imaging for the early diagnosis of local recurrence prostate cancer after radical prostatectomy |
| Q36066851 | An unusual case of fatty liver in a patient with desmoid tumor |
| Q41161920 | Bilateral risk-reduction mastectomy in BRCA1 and BRCA2 mutation carriers: a meta-analysis |
| Q42850920 | Buschke-Löwenstein tumor with squamous cell carcinoma treated with chemo-radiation therapy and local surgical excision: report of three cases |
| Q33772521 | Chemoradiation as definitive treatment for primary squamous cell cancer of the rectum. |
| Q82046004 | Chemotherapy and radiotherapy for anal canal carcinoma |
| Q38769828 | Chyle Leak Following Neck Dissection: Could Radiotherapy Be Considered a Management Option? |
| Q37362938 | Clinical predictive factors of pathologic complete response in locally advanced rectal cancer. |
| Q39173261 | Critical decision-making in radiotherapy for early stage breast cancer in a neo-adjuvant treatment era. |
| Q35817844 | Cytoreduction and HIPEC in the treatment of "unconventional" secondary peritoneal carcinomatosis |
| Q34927668 | Diffusion-weighted magnetic resonance application in response prediction before, during, and after neoadjuvant radiochemotherapy in primary rectal cancer carcinoma |
| Q39940705 | Disease Control, Survival, and Toxicity Outcome After Intensified Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer: A Single-Institution Experience. |
| Q53458819 | Does the addition of induction chemotherapy improve outcome in locally advanced rectal carcinoma? |
| Q37022434 | Efficacy and toxicity of bevacizumab in recurrent ovarian disease: an update meta-analysis on phase III trials |
| Q38691226 | Erythropoiesis-stimulating agents in gynecological malignancies: A study-level meta-analysis |
| Q26784018 | Head and neck cancer: metronomic chemotherapy |
| Q26799812 | Immunotherapy of Ovarian Cancer: The Role of Checkpoint Inhibitors |
| Q40440265 | Impact of Induction Chemotherapy in Locally Advanced HPV-negative Oropharyngeal Cancer. A Propensity Score-matched analysis. |
| Q53377638 | Impact of sphincter invasion on T stage definition in rectal cancer. |
| Q44896094 | Incidence of thromboembolic events in patients with locally advanced rectal cancer receiving neoadjuvant chemoradiotherapy. |
| Q52976279 | Influence of Organ Invasion in Clinical Outcomes for Locally Advanced Rectal Cancer. |
| Q47805696 | Intra-operative radiation therapy (IORT) in recurrent head and neck cancer |
| Q83672876 | Irradiated fields spared Stevens-Johnson syndrome in a patient undergoing radiotherapy for bone metastases |
| Q53506070 | Locally advanced anal canal carcinoma: is the addition of cetuximab the answer? |
| Q35086388 | Management of persistent anal canal carcinoma after combined-modality therapy: a clinical review. |
| Q38680097 | Management of radiation therapy patients with cardiac defibrillator or pacemaker |
| Q87037445 | Mastication structures definition in head and neck cancer |
| Q86628313 | Metabolic atrophy and 3-T 1H-magnetic resonance spectroscopy correlation after radiation therapy for prostate cancer |
| Q54765174 | Metronomic chemotherapy in head and neck cancer. |
| Q35526713 | Neoadjuvant chemoradiotherapy for locally advanced rectal cancer: The debate continues |
| Q34743672 | Neoadjuvant-intensified treatment for rectal cancer: time to change? |
| Q38831001 | New Approaches in Glioblastoma Multiforme: The Potential Role of Immune- check Point Inhibitors |
| Q87819224 | Oral cancer during pregnancy |
| Q39002584 | Osteoradionecrosis and intensity modulated radiation therapy: An overview |
| Q86998598 | Osteoradionecrosis: an old toxicity in the IMRT era? |
| Q47100673 | Palliative treatment of bone metastases: analysis of biological effects of MR guided Focused Ultrasound (MRgFUS) versus External Beam Radiation Therapy (EBRT). A randomized comparative trial using Functional Diffusion Maps as molecular activity indi |
| Q54613465 | Performance of diffusion-weighted imaging, perfusion imaging, and texture analysis in predicting tumoral response to neoadjuvant chemoradiotherapy in rectal cancer patients studied with 3T MR: initial experience. |
| Q37417417 | Preoperative chemoradiotherapy in elderly patients with locally advanced rectal cancer |
| Q43437979 | Prostate cancer recurrence after radical prostatectomy: the role of 3-T diffusion imaging in multi-parametric magnetic resonance imaging |
| Q36320512 | Pulsed-Dose Rate Brachytherapy for the Treatment of Endometrial Cancer. |
| Q53114788 | Radiation target volume definition after induction chemotherapy in locally advanced rectal cancer. |
| Q53980225 | Relation between Hypofractionated Radiotherapy, Toxicity and Outcome in Early Breast Cancer. |
| Q34212998 | Relationship of clinical and pathologic nodal staging in locally advanced breast cancer: current controversies in daily practice? |
| Q27003935 | Risk-reducing salpingo-oophorectomy: a meta-analysis on impact on ovarian cancer risk and all cause mortality in BRCA 1 and BRCA 2 mutation carriers |
| Q40375360 | Second cancer incidence in primary mediastinal B-cell lymphoma treated with methotrexate with leucovorin rescue, doxorubicin, cyclophosphamide, vincristine, prednisone, and bleomycin regimen with or without rituximab and mediastinal radiotherapy: Re |
| Q38985983 | Solitary rib metastasis of nasopharyngeal carcinoma |
| Q35625617 | Squamous cell carcinoma of the rectum: The treatment paradigm. |
| Q53339284 | Target volume delineation after induction chemotherapy in locally advanced head and neck cancer. |
| Q50995125 | Texture analysis as imaging biomarker of tumoral response to neoadjuvant chemoradiotherapy in rectal cancer patients studied with 3-T magnetic resonance. |
| Q39114121 | The role of radiation therapy in bone metastases management |
| Q38954891 | Treatment Complications and Long-term Outcomes of Total Body Irradiation in Patients with Acute Lymphoblastic Leukemia: A Single Institute Experience |
| Q34676868 | Treatment improvement and better patient care: which is the most important one in oral cavity cancer? |
| Q38630990 | Tyrosine-kinases inhibitors in recurrent platinum-resistant ovarian cancer patients. |
| Q95548175 | Unenhanced whole-body MRI versus PET-CT for the detection of prostate cancer metastases after primary treatment |
| Q46675123 | Vitamin D protects endothelial cells from irradiation-induced senescence and apoptosis by modulating MAPK/SirT1 axis. |
| Q37629090 | Weekly versus three weeks chemotherapy for advanced ovarian cancer: a meta-analysis |
| Q38776254 | c-Myc Sustains Transformed Phenotype and Promotes Radioresistance of Embryonal Rhabdomyosarcoma Cell Lines. |
Search more.